Potent P2Y14 receptor agonist (EC50 = 49 nM) that displays 7-fold higher potency than UDP-glucose.
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 626.33. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.6 mL||7.98 mL||15.97 mL|
|5 mM||0.32 mL||1.6 mL||3.19 mL|
|10 mM||0.16 mL||0.8 mL||1.6 mL|
|50 mM||0.03 mL||0.16 mL||0.32 mL|
References are publications that support the products' biological activity.
Ko et al (2007) Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptor. J.Med.Chem. 50 2030 PMID: 17407275
If you know of a relevant reference for MRS 2690, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: MRS 2690, supplier, Potent, P2Y14, agonists, Receptors, Purinergic, purinoceptors, MRS2690, Purinergic, P2Y, Receptors, Purinergic, P2Y, Receptors, Tocris Bioscience
1 Citation for MRS 2690
Citations are publications that use Tocris products. Selected citations for MRS 2690 include:
Gao et al (2013) The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells. Neuropsychopharmacology 9 31 PMID: 22825617
Do you know of a great paper that uses MRS 2690 from Tocris? If so please let us know.
MRS 2690 Reviews
Average Rating:(Based on 0 Reviews)